Skip to Main Content
×
Quiver Logo Get a Free Trial on Quiver Premium Today!
Back to News

UnitedHealth Group Stock (UNH) Opinions on Analyst Upgrades and AI Investments

None

Analyst Upgrades: Social media discussions have centered on recent analyst actions, including multiple price target increases following UnitedHealth's solid first-quarter performance. Observers note the company's decision to raise its full-year earnings guidance, with some highlighting Optum's margin progress as a positive factor. The stock's rebound from earlier lows has drawn attention amid these developments.

AI Investments: Another focal point involves the planned three-billion-dollar commitment to artificial intelligence through 2027. Participants describe how these initiatives aim to enhance medical record summaries and appointment scheduling. This strategy is frequently linked to broader operational efficiencies in healthcare.

Dividend and Outlook: Commentary also touches on the recent dividend increase as a sign of confidence in the integrated business model. Users reference upcoming second-quarter results as a potential catalyst for further conversation. Overall engagement reflects steady interest in the company's trajectory ahead of those updates.

Note: This discussion summary was generated from an AI condensation of post data.

EARLY ACCESS
Receive UNH Data Alerts
Real-time alerts on filings, insider trades, and market signals — before everyone else.
Get Alerts →

UnitedHealth Group Revenue

UNH Quarterly Revenue

UnitedHealth Group had revenues of $111.7B in Q1 2026. This is an increase of 1.96% from the same period in the prior year.

You can track UNH financials on Quiver Quantitative's UNH stock page.

You can access data on UNH stock through the Quiver Quantitative API.

UnitedHealth Group Congressional Stock Trading

Members of Congress have traded $UNH stock 9 times in the past 6 months. Of those trades, 7 have been purchases and 2 have been sales.

Here’s a breakdown of recent trading of $UNH stock by members of Congress over the last 6 months:

To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.

UnitedHealth Group Hedge Fund Activity

We have seen 1,345 institutional investors add shares of UnitedHealth Group stock to their portfolio, and 1,970 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.

UnitedHealth Group Government Contracts

We have seen $15,182,689,096 of award payments to $UNH over the last year.

Here are some of the awards which we have have seen pay out the most over the last year:

To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.

UnitedHealth Group Analyst Ratings

Wall Street analysts have issued reports on $UNH in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Mizuho issued a "Outperform" rating on 02/05/2026
  • Truist Securities issued a "Buy" rating on 02/02/2026
  • Barclays issued a "Overweight" rating on 01/30/2026
  • Wells Fargo issued a "Overweight" rating on 01/30/2026
  • Jefferies issued a "Buy" rating on 01/28/2026
  • Leerink Partners issued a "Outperform" rating on 01/28/2026

To track analyst ratings and price targets for UnitedHealth Group, check out Quiver Quantitative's $UNH forecast page.

UnitedHealth Group Price Targets

Multiple analysts have issued price targets for $UNH recently. We have seen 19 analysts offer price targets for $UNH in the last 6 months, with a median target of $409.0.

Here are some recent targets:

  • Whit Mayo from Leerink Partners set a target price of $462.0 on 06/17/2026
  • Ann Hynes from Mizuho set a target price of $460.0 on 06/08/2026
  • Lisa Gill from JP Morgan set a target price of $466.0 on 06/08/2026
  • Erin Wright from Morgan Stanley set a target price of $453.0 on 06/04/2026
  • Kevin Fischbeck from B of A Securities set a target price of $450.0 on 06/04/2026
  • David Macdonald from Truist Securities set a target price of $440.0 on 06/01/2026
  • Lance Wilkes from Bernstein set a target price of $492.0 on 05/27/2026

This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.

Add Quiver Quantitative to your preferred sources on Google Google News Logo

Suggested Articles